Narratives of twenty to thirty year outcomes in schizophrenia

Psychiatry (New York)

Volumn 61, Issue 3, 1998, Pages 249-261

  Seeman, Mary V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031727993     PISSN: 00332747     EISSN: 1943281X     Source Type: Journal    
DOI: 10.1521/00332747.1998.11024836     Document Type: Article

References (31)

1. Angermeyer, M.C., Kuhn, L., and Goldstein, J.M. Gender and the course of schizophrenia differences in treated outcomes. Schizophrenia Bulletin (1990) 16:293-307.
2. Bleuler, M. The long-term course of the schizophrenic psychoses. Psychological Medicine (1974) 4:244-54.
3. Castle, D.J., Abel, K., Takei, N., and Murray, R.M. Gender differences in schizophrenia: Hormonal effect or subtypes? Schizophrenia Bulletin (1995) 21: 1–12.
4. Ciompi, L. The natural history of schizophrenia in the long term. British Journal of Psychiatry (1980) 136:413-20.
5. Davidson, L., and McGlashan, T.H. The varied outcomes of schizophrenia. Canadian Journal of Psychiatry (1997) 42:34-43.
6. Dipaolo, T. Modulation of brain dopamine transmission by sex steroids. Beview of Neuroscience (1994) 5:27-42.
7. Fennig, S., Putnam, K., Bromet, E.J., and Galambos, N. Gender, premorbid characteristics and negative symptoms in schizophrenia. Acta Psychiat-rica Scandinavica (1995) 92:173-7.
8. Foerster, A., Lewis, S., Owen, M., and Murray R. Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis. British Journal of Psychiatry (1991) 158:171-6.
9. Goldstein, J. Gender and familial transmission of schizophrenia. In M.V. Seeman, ed., Gender and Psychopathology, (pp. 201–226). American Psychiatric Press, 1995.
10. Häfner, H., and an der Heiden, W. Epidemiology of schizophrenia. Canadian Journal of Psychiatry (1997) 42:139-51.
11. Häfner, H., Behrens, S., De Vry, J., and Gattaz, W.F. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic transmission. European Archives of Psychiatry and Clinical Neuroscience (1991) 241: 65-8
12. Harding, C.M., Brooks, G.Wl, Ashikaga, T., Strauss, S.S., and Breiek, A. The Vermont longitudinal study of persons with severe mental illness. I Methodology, study sample and overall status 32 years later. American Journal of Psychiatry (1987) 144:718-26.
13. Harrison, G., Croudace, P., Mason, C., Glaze-brook, C., and Medley, I. Predicting the long-term outcome of schizophrenia. Psychological Medicine (1996) 26:697-705.
14. Huber, G., Gross, G., and Schüttler, R. A longterm follow-up study of schizophrenia: Psychiatric course of illness and prognosis. Acta Psychiatrica Scandinavica (1975) 52:49-57.
15. Jonsson, H., and Nyman, K. Prediction of outcome in schizophrenia. Acta Psychiatrica Scandinavica (1984) 69:274-91.
16. Jonsson, H., and Nyman, A.K. Predicting long-term outcome in schizophrenia. Acta Psychiatrica Scandinavica (1991) 83:342-6.
17. Mason, P., Harrison, G., Glazebrook, G., Medley, I., Dalkin, T., and Croudace, T.J. The characteristics of outcome in schizophrenia at 13 years. British Journal of Psychiatry (1995) 167:596-603.
18. McGlashan, T.H. Predictors of shorter-medium -and longer-term outcome in schizophrenia. American Journal of Psychiatry (1986a) 143:50-5.
19. McGlashan, T.H. The prediction of outcome in chronic schizophrenia. IV The Chestnut Lodge follow-up study. Archives of General Psychiatry (1986b) 43:167-76.
20. McGlashan, T.H. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophrenia Bulletin (1988) 14:515-42.
21. Mueser, K.T., Bellack, A.S., Morrison, R.L., and Wixted, J.T. Social competence in schizophrenia: Premorbid adjustment, social skill, and domains of functioning. Journal of Psychiatric Research (1990) 24:51-63.
22. Nyman, A.K., and Jonsson, H. Differential evaluation of outcome in schizophrenia. Acta Psychiatrica Scandinavica (1983) 68:458-75.
23. Opjordsmoen, S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatrica Scandinavica (1991) 83:307-13.
24. Ram, R., Bromet, E.J., Eaton, W.W., Pato, C., and Schwartz, J.E. The natural course of schizophrenia: A review of first admission studies. Schizophrenia Bulletin (1992) 18:185-207.
25. Riecher-Rössler, A., Fätkenheurer, B., Löffler, W., Maurer, K., and Häfner, H. Is age of onset in schizophrenia influenced by marital status? Social Psychiatry and Psychiatric Epidemiology (1992) 7: 122–8.
26. Riecher-Rössler, A., and Häfner, H. Schizophrenia and oestrogens—is there an association? European Archives of Psychiatry and Clinical Neuroscience (1993) 242:323-8.
27. Riecher-Rössler, A., Häfner, H., Stumbaum, M., Maurer, K., and Schmidt, R. Can oestradiol modulate schizophrenic symptomatology? Schizophrenia Bulletin (1994) 2:203-14.
28. Salokangas, R.K.R. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophrenia Research (1995) 16: 7–16.
29. Seeman, M.V. The role of estrogen in schizophrenia. Journal of Psychiatry and Neuroscience (1996) 21: 123–7.
30. Sham, P.C., Gottesman, I.I., MacLean, C.J., and Kendler, K.S. Sex and familial morbidity. Psychiatry Research (1994) 52:125-34.
31. Steinmeyer, E.M., Marneros, A., Deister, A., Rhode, A., and Junemann, H. Long-term outcome of schizoaffective and schizophrenic disorders: A comparative study II. Causal-analytical investigations. European Archives of Psychiatry and Clinical Neuroscience (1989) 238:126-34.